Paul Sufka, MD psufka
8 years ago
#ACR18 social media dinner with @rheumecraig @samwhittle @DrBhana @alhkim @jeffsparks @EBRheum @PhilipGardiner @BeckySueToo https://t.co/Kw0FejsnIE
Paul Sufka, MD psufka
8 years ago
Here's a view from the other direction from @DrBhana's phone. #ACR18 https://t.co/P6Ewkw3fxC
Paul Sufka, MD psufka
8 years ago
Thread: #ACR18 Round up with @RheumNow & Dr Kavanaugh. https://t.co/xqOs5LjwGi
Paul Sufka, MD psufka
8 years ago
Abstract 428. Pain reduction over 12 months using methotrexate for knee osteoarthritis. Good study: RCT, 12 months, statistically significant pain reduction in knee pain. (by comparison, MTX doesn't work for hand OA) #ACR18 https://t.co/lwdNNZvR0R
Paul Sufka, MD psufka
8 years ago
Abstract 221: DIP involvement in RA is about 2%. More women than men, and more in pts with higher disease activity. Might be poor prognostic indicator. #ACR18 https://t.co/YQR8kknRTl
Paul Sufka, MD psufka
8 years ago
Abstract 2220: gout flares and allopurinol use population study. Unfortunately, gout is *vastly* undertreated. Similar abstracts 1247, 1272 show that pharmacist driven gout care can work well #ACR18 https://t.co/09A85ehnf1
Paul Sufka, MD psufka
8 years ago
Abstract 404: using IL-17 inhibitor to treat supraspinatus tendinopathy in a rat model. This is a common shoulder tendinopathy, and IL-17 Involved in human cases. #ACR18 https://t.co/KwK6slNqA5
Paul Sufka, MD psufka
8 years ago
Abstract 2264: data to support use of methotrexate in granulomatous mastitis with good results. (Be aware of this condition - you *will* eventually see it) #ACR18 https://t.co/SsDdz21t5r
Paul Sufka, MD psufka
8 years ago
My article on @RheumNow: 'Negotiation Skills for Rheumatologists' https://t.co/NfsTXd9qLK #ACR18
Philip Gardiner PhilipGardiner
8 years ago
Tocilizumab is an option in treating severe Thyroid eye disease #ACR18 https://t.co/I3iq8uOibh
Cassandra Calabrese CCalabreseDO
8 years ago
checkpoint inhibitor-related myositis has unique phenotype - myocarditis, myasthenia gravis-like symptoms abstract #2976 #ACR18 @RheumNow
Dr. Naomi Schlesinger: Pegloticase Trial
Dr. Naomi Schlesinger discusses gout presentations at the 2018 ACR/ARHP Annual Meeting in Chicago.
ǝlʇʇıɥʍ ɯɐs samwhittle
8 years ago
Take-home message from the basic science Year in Review is that TLR7 links together all this year’s novel findings in SLE pathogenesis. #ACR18 @RheumNow
ǝlʇʇıɥʍ ɯɐs samwhittle
8 years ago
Pascual Year in Review: Gut pathogen (E gallinarum) translocated to liver, drives murine SLE. Treatable with antibiotics or vaccination. #ACR18 @RheumNow https://t.co/C5dSvnSQZz
ǝlʇʇıɥʍ ɯɐs samwhittle
8 years ago
Merkel Year in Review: SPACE trial (JAMA 18) - opioids NOT superior to NSAIDs for function or pain in OA & back pain. #ACR18 @RheumNow https://t.co/jQgc1eR67E

